Key points are not available for this paper at this time.
Minimal change disease (MCD) is a major cause of adult-onset nephrotic syndrome, particularly in Japan where it affects 40% of patients compared with15% of patients world-wide.1 Its incidence is particularly high among the elderly and both the disease and corticosteroid therapy can be a major cause of morbidity in this population.
Fujita et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: